PI3Kα-IN-22
Product Specifications
UNSPSC Description
PI3Kα-IN-22 (Compound 17) is an orally active, potent and selective inhibitor of PI3KαH1047R, with an IC50 of 1 nM for pAKT T47D AlphaLISA. PI3Kα-IN-22 can induce tumor regressions in the HCC1954 tumor model in mice[1].
Target Antigen
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pi3kα-in-22.html
Solubility
10 mM in DMSO
Smiles
CC(C=C([C@H](NC1=CC=CC=C1C(O)=O)C)C2=NC(N3CCC(F)(F)CC3)=C4C#N)=CN2C4=O
Molecular Weight
467.47
References & Citations
[1]Ketcham JM, et al. Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein. J Med Chem. 2024 Mar 28;67(6):4936-4949.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161373/PI3Kα-IN-22-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161373/
Clinical Information
No Development Reported
CAS Number
2925030-26-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RC220053L4V 200 µL
Endothelin 3 (EDN3) (NM_000114) Human Tagged ORF Clone Lentiviral Particle
Ask
View Details 
MBS6163032-01 0.1 mL
DYRK2 (Dual-Specificity Tyrosine-(Y)-phosphorylation Regulated Kinase 2, FLJ21217, FLJ21365) (AP)
Ask
View Details MBS6163032-02 5x 0.1 mL
DYRK2 (Dual-Specificity Tyrosine-(Y)-phosphorylation Regulated Kinase 2, FLJ21217, FLJ21365) (AP)
Ask
View Details 